The glutathione-dependent system is one of the key systems regulating cellular redox balance, and thus cell fate. Cysteine, typically present in its oxidized form cystine in the extracellular space, is regarded as the rate-limiting substrate for glutathione (GSH) synthesis. Cystine is transported into cells by the highly specific amino-acid antiporter system x c À . Since Burkitt's Lymphoma (BL) cells display limited uptake capacity for cystine, and are thus prone to oxidative stress-induced cell death, we stably expressed the substrate-specific subunit of system x c À , xCT, in HH514 BL cells. xCT-overexpressing cells became highly resistant to oxidative stress, particularly upon GSH depletion. Contrary to previous predictions, the increase of intracellular cysteine did not affect the cellular GSH pool, but concomitantly boosted extracellular cysteine concentrations. Even though cells were depleted of bulk GSH, xCT overexpression maintained cellular integrity by protecting against lipid peroxidation, a very early event in cell death progression. Our results show that system x c À protects against oxidative stress not by elevating intracellular GSH levels, but rather creates a reducing extracellular environment by driving a highly efficient cystine/cysteine redox cycle. Our findings show that the cystine/cysteine redox cycle by itself must be viewed as a discrete major regulator of cell survival.
Introduction
Redox regulation of cell cycle progression and cell death has attracted remarkable interest in recent years (Arner and Holmgren, 2000) . A variety of enzymatic systems are involved in the maintenance of intracellular redox homeostasis including the glutathione and thioredoxindependent systems. Starting to dissect their functional redundancy, we have created mice with targeted deficiencies for both cytosolic and mitochondrial thioredoxin reductases (Txnrd1 and 2, Conrad et al., 2004; Jakupoglu et al., 2005) . Thereby, we could demonstrate that Txnrd2 indeed efficiently protects cells against the detrimental effects of GSH depletion (Conrad et al., 2004) .
Glutathione is present in cells in millimolar concentration and is considered as the major natural antioxidant, protecting cells from oxidative stress (Meister, 1995) . Availability of cystine/cysteine is the rate-limiting step in GSH synthesis (Bannai and Tateishi, 1986; Ishii et al., 1987) . Cysteine is transported into cells via neutral amino-acid transport systems, whereas cystine, the predominant form in plasma, extracellular body fluids and cell culture medium, is carried by the anionic amino-acid transport system, system x c À (Bannai and Tateishi, 1986) . Expression of system x c À is fairly low in many cell types as firstly depicted for murine B lymphocytes. Provision of b-mercaptoethanol (2-ME) or other sulfhydryl-containing compounds is thus a prerequisite for the survival of those cells in vitro (Broome and Jeng, 1973; Metcalf, 1976) . Thiol-containing compounds form mixed disulfides and thereby release cysteine which eventually enters cells via neutral amino-acid transport systems. The mixed disulfides in turn enter the cell via a transport system for bulky amino acids, releasing cysteine intracellularly. Thiol compounds are, however, not required if B cells are cocultured with irradiated fibroblasts. Fibroblasts have a high uptake capacity for cystine, and upon intracellular reduction, provide cysteine to co-cultured B cells .
Limited uptake capacity for cystine is a phenomenon neither restricted to murine cells nor to B cells. T cells are dependent on the supply of cysteine by antigenpresenting cells (Droge et al., 1991; Kuppner et al., 2003) . Proliferation of many human and murine lymphoma and leukemia cell lines are dependent on free thiols or a feeder layer of irradiated fibroblasts (Falk et al., 1993 . Likewise, neurons show limited uptake capacity for cystine which may lead to low intracellular GSH concentrations and high susceptibility to oxidative stress-induced cell death (Murphy et al., 1989 (Murphy et al., , 1990 .
The x c À cystine/glutamate-exchange transporter is a heterodimer composed of the xCT light chain conferring the specificity of the amino-acid exchange reaction, and the 4F2 heavy chain, a ubiquitously expressed cell surface component shared with several other amino-acid transport systems (Sato et al., 1999; Verrey et al., 2000) . The xCT light chain consists of 12 putative transmembrane domains and is linked to the 4F2 heavy chain through an extracellular disulfide bond (Sato et al., 1999) . Transcription of the xCT gene and x c À transport activities are induced by oxidative stress, mediated by electrophilic agents, depletion of cystine and by oxygen (Bannai et al., 1989) . xCT-deficient mice are viable and fertile indicating that the supply of cysteine can be compensated by other routes during normal development. By contrast, fibroblasts isolated from xCT À/À mice can only be cultivated if the culture medium is supplemented with 2-ME or N-acetylcysteine (NAC, Sato et al., 2005) .
To study the contribution of system x c À to the redox balance in proliferation and prevention of human B cells from oxidative stress-induced cell death, we have established a BL cell line that stably expresses xCT light chain. Our data demonstrate that elevated expression of xCT efficiently protects BL cells from oxidative stressinduced cell death even under conditions of cellular GSH depletion.
Results
L-cystine uptake is strongly increased in xCT-overexpressing cells and is sensitive to inhibition by L-glutamate Human and murine xCT light chain were cloned into the expression vector p141CAG-3SIP and used for stable expression in HH514 BL cells. For each gene, three independent clones were selected with puromycin and constantly maintained under selection pressure. Expression levels were analysed by northern blotting of total RNA, isolated from empty vector-transfected and xCToverexpressing cells. By using an xCT-specific cDNA probe, strong hybridization signals, corresponding to the bicistronic xCT-IRES-puromycin acetyl transferase mRNA of about 3.5 kb, were detected ( Figure 1b) . The endogenous xCT mRNA of 12.5 kb became visible after extended exposure (Figure 1b) . L-cystine uptake activity was determined in vector-and xCT-transfected cells. Figure 1c shows a time course of L-cystine uptake (0.1 mCi per sample) in non-transfected cells, vectortransfected cells and hxCT-overexpressing cells for the time intervals of 1, 2 and 3 min. L-cystine uptake was virtually undetectable in untransfected and vectortransfected cells, whereas xCT-transfected cells showed an uptake activity of more than 2 nmol min À1 per mg protein, which was linear at least for the first 3 min. Uptake of L-cystine was efficiently inhibited in the presence of 2.5 mM L-glutamate, indicating that L-cystine uptake is solely mediated by the cystine-glutamate exchange transporter (Figure 1d ). Seeding BL cells at low cell density generates oxidative stress which can be overcome by the addition of antioxidant supplements (Falk et al., 1993; Brielmeier et al., 1998) . To investigate whether overexpression of human xCT provides a growth advantage to HH514 cells, a critical cell density was determined that discriminates between cell survival/ proliferation and cell death. Cells were plated in 96-well plates in serial dilutions from 10 000 cells per well (100 000 cells ml
À1
) down to 20 cells per well. For untransfected and vector-transfected control cells, the critical cell density was 50 000 cells ml À1 , whereas overexpression of human xCT supported cell growth to a density as little as 6000 cells ml À1 (Figure 1e ).
xCT-overexpressing HH514 cells are highly resistant to L-buthionine-sulfoximine-(BSO) mediated cell death Next, we examined whether xCT-overexpression supports growth of BL cells even under strongly limiting GSH conditions. To this end, HH514 cells were cultivated in the presence of various L-buthioninesulfoximine (BSO) concentrations, and the number of viable and dead cells was determined over a period of 8 days (Figures 2a and b) . We used BSO in our studies, since BSO specifically inhibits g-glutamyl-cysteine synthetase (g-GCS), the rate-limiting enzyme in GSH anabolism, and thus causes rapid depletion of intracellular GSH (Griffith, 1982) . While control cells already died at the lowest BSO concentration within 48 h, proliferation of xCT-overexpressing cells was slowed down in a dose-dependent manner and cells remained viable even in the presence of 100 mM BSO (Figure 2b ). BSO treatment did not impair the uptake capacity of cells for cystine (Figure 2c ). Addition of 2.5 mM GSH rescued the BSO-mediated decrease in proliferation rate, again with lesser efficiency at high BSO concentrations, ruling out a toxic side effect of BSO (Figure 2d) .
A decrease in the proliferation rate of BSO-treated cells might be caused by an increase in the number of cells exiting the cell cycle and entering G 0 or G 1 , by an increased death rate in the BSO-treated culture that diminishes the number of cells without affecting the cell cycle distribution, or both. To discriminate between these possibilities, the cell cycle distribution of xCT overexpressing cells was studied that had been treated with 50 mM BSO. As shown in Figure 2e , the ratio of cells in G 1 to those in G 2 remained unaffected, while the number of dead cells (sub-G 1 ) increased from 6.3 to 25% in the presence of BSO. The number of cells in S phase decreased to some extent suggesting that cells in
The cystine/cysteine redox cycle A Banjac et al S phase are more prone to oxidative stress-induced cell death.
To correlate intracellular GSH levels with survival and proliferation, cells were treated with different concentrations of BSO, and GSH concentrations were determined after 24 h of incubation, a time point when the number of viable control cells had not yet decreased. As shown in Figure 3a , no relevant change in GSH levels of xCT-overexpressing cells and control cells was detectable at any given BSO concentration. Most importantly, empty vector-transfected cells treated with 5 mM BSO died within 48 h (Figure 2a) , whereas xCToverexpressing cells continued to proliferate under the same conditions (Figure 2b ), despite equal low GSH levels ( Figure 3a) . Moreover, xCT-overexpressing cells sustained cell survival even at significantly lower GSH levels due to higher BSO concentrations as compared to control cells treated with only 5 mM BSO (Figure 3a ). In addition, intracellular GSH became even undetectable by HPLC analysis in BSO-treated cells irrespective of xCT-expression levels ( Figure 3b ). These unexpected findings strongly argue against a putative, critical threshold of GSH that discriminates between cell survival and cell death. Our data imply that HH514 cells can survive and proliferate at strongly decreased GSH levels provided that sufficient L-cystine uptake is guaranteed by system x c
Intra-and extracellular L-cysteine levels are strongly augmented in xCT-overexpressing cells Since increased cystine uptake activity rescued xCToverexpressing cells from BSO-induced cell death, and GSH did not play the suspected role in maintaining cell survival, we focussed on the fate of intracellular cystine. As expected, a consistent increase of intracellular cysteine by a factor of about 6 was observed in xCToverexpressing cells (Figure 4a ). However, when we studied extracellular total mercaptan levels, we observed remarkably higher levels in xCT-overexpressing cells regardless of BSO treatment ( Figure 4b ). In contrast, only marginal levels were secreted by control cells. HPLC analysis revealed that secreted mercaptans consist predominantly of cysteine ( Figure 4c ). These data support the notion that system x c À drives a redox cycle consisting of cystine import, intracellular reduction of cystine to cysteine, cysteine secretion and reoxidation to cystine in the extracellular environment. L-cystine uptake was inhibited by glutamate. L-cystine uptake was measured for 1 min in the absence (filled bars) or presence (empty bars) of 2.5 mM glutamate (Glu) resulting in 87% inhibition by glutamate. A clear decrease was also noticed in empty vectortransfected cells. (e) Cell survival was monitored three weeks after seeding. The critical cell density for survival and proliferation of non-transfected BL cells (') and cells transfected with the empty vector (m) was between 100 000 and 50 000 cells ml
. (E) In the presence of 100 mM a-thioglycerol (a-TG), and 3 mM pyruvate nontransfected BL were capable of proliferating at cell densities of 200 cells ml À1 . Overexpression of human () and murine xCT (x) in BL cells supported growth at densities of about 6000 cells ml À1 and higher. Results represent mean values of four independent experiments with duplicate measurements7s.d.
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A Banjac et al xCT-overexpression protects HH514 cells from hydrogen peroxide induced cell death To address whether xCT overexpression is able to protect HH514 cells also from other death-inducing stimuli, xCT overexpressing HH514 and control cells were treated with increasing concentrations of hydrogen peroxide. As shown in Figure 5a , xCT-overexpressing cells were more resistant to hydrogen peroxide treatment than untransfected or mock-transfected control cells.
To study susceptibility of xCT-overexpressing cells and control cells to killing through death receptors, expression of CD95 and of the death receptors DR4 and DR5 was studied by flow cytometry (Figure 5b) . Expression of neither CD95, nor DR4 and DR5 was affected by overexpression of xCT. CD95 was expressed at very low levels on HH514, mock-transfected and xCT-transfected cells, whereas the majority of cells stained positive for DR4 and about half of the cells for DR5 (Figure 5b) . Treatment of the cells with CD95/Fas ligand (FasL) did not induce cell death consistent with the low CD95 expression on the cell surface. Mocktransfected and xCT-transfected HH514 cells were also resistant to killing by TRAIL independently of the (Figure 6 ), suggesting that loss of mitochondrial integrity initiates the execution phase of BSO-induced cell death associated with broad caspase activation and DNA fragmentation (Supplementary Figure 3) .
If lipid peroxidation and subsequent breakdown of membrane integrity trigger BSO-induced cell death, antioxidants specifically targeting lipid membranes should protect cells from BSO-induced cell death. As shown in Figure 7a , treatment of control cells with vitamin E fully protected HH514 cells from lipid peroxidation and cell death. xCT-overexpressing cells but not vector-transfected HH514 cells were protected from lipid peroxidation (Figure 7b ). In line with the data described in Figure 2 , lipid peroxidation increased in vector-transfected cells with increasing BSO concentration, and likewise, protection from lipid peroxidation by xCT overexpression was less complete at higher BSO concentration (Figure 7b ).
Discussion
To investigate the role of cystine uptake for the regulation of cell survival and proliferation, we established HH514 BL cell clones that stably overexpress human xCT light chain of the x c À cystine/glutamate exchange transporter. Our data show that overexpression of xCT light chain promotes a strong increase in the uptake activity for L-cystine and protects HH514 cells The cystine/cysteine redox cycle A Banjac et al from oxidative stress-induced cell death. The protective effect of xCT is not associated with changes in the expression level of various pro-or antiapoptotic genes.
Availability of cysteine is regarded as the substratelimiting step in GSH synthesis (Ishii et al., 1987) , and we therefore investigated whether increased cystine uptake impacts the intracellular GSH pool. We included BSO, the most powerful inhibitor of GSH synthesis, in our analyses to correlate survival and proliferation of control and xCT-overexpressing cells with intracellular GSH levels. Side effects of BSO could be excluded as addition of GSH rescued the effect of BSO on survival and proliferation of HH514 cells. At high BSO concentrations, the protective effect of xCT overexpression on cell survival was less complete suggesting that high BSO concentrations select for high xCT expression and cells with lower xCT expression are killed by BSO in this experimental setting. Unexpectedly, xCT-overexpression does not fuel intracellular GSH levels either in the absence or in the presence of a wide range of different BSO concentrations (Figure 3) . In fact, the increased cystine uptake leads to about six-fold increase in intracellular and to an even more pronounced increase in extracellular cysteine levels. These high cysteine levels are obviously sufficient to sustain cell growth of xCT-overexpressing cells even under conditions of strongly reduced GSH levels. Hence, our results do not support the idea of a putative threshold of GSH that decides on cell survival or cell death. In fact, system x c À drives a distinct cystine/cysteine cycle that efficiently protects cells from detrimental lipid peroxidation, a very early event in the onset of BSO-induced cell death starting about 8 h after the addition of BSO. Lipid peroxidation is initiated much earlier than ROS accumulation (24 h) and breakdown of the mitochondrial membrane potential (30 h) suggesting that lipid peroxidation is the causal and initiating event in the course of cell death induction. This is strongly supported by our finding that cell death induced by BSO-mediated GSH depletion is completely rescued by the lipophilic antioxidant vitamin E. Breakdown of the mitochondrial membrane potential is a comparatively late event that presumably initiates the execution phase of cell death associated with broad caspase activation, DNA fragmentation and Annexin V/PI staining. The bulk antioxidant function of cellular GSH can thus be substituted by the cystine/cysteine cycle, though it cannot be ruled out at present whether small amounts of GSH are indispensable for other aspects in cellular functions. For instance, it was shown recently that GSH is essential for cytosolic Fe-S cluster formation in yeast (Sipos et al., 2002) . Independent evidence that bulk GSH is dispensable for cell proliferation at least in vitro has been provided by genetic means. Targeted inactivation of g-GCS in mice revealed that GSH is essential for embryonic development, but unexpectedly not required for proliferation of blastocyst-derived cell lines in the presence of N-acetylcysteine (Shi et al., 2000) . In vitro experiments with CaCo2 cells showed that the extracellular redox potential defined by the ratio of extracellular cysteine to cystine is critical for cell proliferation and independent of GSH (Jonas et al., 2002; Sonoda et al., 2004) .
The importance of the cystine/cysteine cycle for the resistance of cancer cells to chemotherapy has been recognized only recently (Okuno et al., 2003) . Activation of the xCT gene in cancer cells by cytotoxic drugs may be a mechanism contributing to chemotherapy resistance in vivo, a possibility that apparently deserves further studies. It is another important issue whether the limitation of cystine uptake, as observed in various cell lines, has any pathophysiological impact. As proposed by Ye and Sontheimer (1999) , in the central nervous system, deregulated activity of the cystine/cysteine cycle, as observed in human malignant glioma cells, leads to a detrimental increase in secreted glutamate associated with increased glutamate toxicity, neuronal death and seizures. In the hematopoietic system, the particular sensitivity of the cells to ionizing radiation may be related to a limited uptake capacity of cystine. Limited activity of the cystine/cysteine cycle may also be necessary for an orchestrated regulation of apoptosis in the immune system. Low activity of system x c À in B and T cells may be a prerequisite to render the immune system highly dynamic. Redox regulation also appears to be crucially important to fine tune the T helper cell response towards Th1 or Th2 (Peterson et al., 1998) .
In the present work, we provide strong evidence that the cystine/cysteine redox cycle, driven by system x c À , is characterized by slightly increased intracellular and exceedingly high extracellular cysteine concentrations, and efficiently protects cells from oxidative stressinduced cell death. The previous paradigm of augmented GSH levels due to increased cystine availability is not supported by our findings. In fact, we provide experimental evidence that increased cysteine uptake does not alter cellular GSH levels to a significant extent; hence, the cystine/cysteine cycle by itself might be regarded as a major redox system regulating cell survival and cell death.
Materials and methods

Cell line and chemicals
The BL cell line HH514 cells was cultured in RPMI 1640 medium containing 10% fetal bovine serum (FBS) (Biochrom, Berlin, Germany), 100 U ml À1 penicillin, 100 mg ml À1 streptomycin and 2 mM glutamine. L-[ 14 C]Cystine was purchased from Amersham Corp. (Freiburg, Germany) and other chemicals from Sigma (Deisenhofen, Germany), Invitrogen (Karlsruhe, Germany), and ICN (ICN Biomedicals GmbH, Eschwege, Germany). Restriction and DNA-modifying enzymes and DNA linkers were obtained from MBI Fermentas (Vilnius, Lithunia) and Biolabs GmbH (Schwalbach, Germany).
Cloning of mouse and human xCT into an expression vector and stable expression in HH514 cells
The BclI site of pSPORT-mxCT was converted into an EcoRI site and the HindIII site into a NheI site. Murine xCT cDNA was transferred as a HindIII/NheI fragment into the vector p141CAG-3SIP driving expression from a CMV enhancerchicken-b-actin promoter (Niwa et al., 2002; Okita et al., 2004) . For cloning of human xCT, a synthetic linker carrying EcoRI, BstBI, BglII and NheI sites (MCa: 5 0 -ATTTCATTCG AACGG AGATCTTG-3 0 ; MCb: 5 0 -CTAGCATGA TCTCC GTTCGAATG-3 0 ) was cloned in p141CAG-3SIP digested with EcoRI and HindIII. Human xCT cDNA was excised from a pBluescript SK clone as a ClaI/BglII fragment and inserted into the modified p141CAG-3SIP vector between the BstBI and BglII sites. Transfections of the cell line HH514 with xCTexpressing or empty vectors were performed as described previously . Stably transfected clones were selected with puromycin at a final concentration of 2 mg ml À1 .
Northern blot analysis
Total RNA was isolated using Qiagen RNeasy Midi Kit according to the manufacturer's instructions (Qiagen, Hilden, The cystine/cysteine redox cycle A Banjac et al Germany). Total RNA (10 mg) per cell clone were blotted and detection of human and murine xCT-expression was performed with radiolabelled human-and mouse-specific cDNA probes.
Measurement of L-cystine transport activity Uptake of L-cystine was measured as described (Novogrodsky et al., 1979; Sato et al., 1995) .
Viability assay
Cells were plated in 6-well plates at 1 Â 10 5 cells ml À1 in 3 ml standard medium supplemented with different BSO concentrations. The number of viable cells was determined by trypan blue exclusion or PI staining by flow cytometry.
Glutathione content (Tietze) Total glutathione (GSH and GSSG) was extracted with 5% trichloroacetic acid from cells grown in 10 or 200 ml flasks. Total glutathione was measured as outlined previously (Bannai and Ishii, 1982) . The method is based on the reduction of 5,5 0 -dithiobis-2-nitrobenzoic acid by GSH which in turn is reduced by glutathione reductase (Tietze, 1969) . Intracellular GSH was additionally determined by HPLC analysis (see below).
Determination of total thiols in the medium
Total mercaptans secreted into the cell culture medium were determined as described previously (Bannai and Ishii, 1982) . GSH was used as a standard.
HPLC determination of extra-and intracellular cysteine Determination of cysteine in cell culture supernatants was performed by a HPLC after derivatization of the free sulfhydryl group with SBDF (7-fluoro-benzo-2-oxa-1,3-diazole-4-sulphonate) as described previously with slight modifications (Feussner et al., 1997) . A measure of 2 Â 10 6 cells were washed, resuspended in 2 ml of serum-free medium and incubated for 2 h at 37 1C. Cells were collected by centrifugation and 100 ml of the supernatant were mixed with 100 ml 2 M borate buffer (containing 5 mM Na 2 EDTA, pH 10.05 and 100 ml SBDF (1 mg ml À1 in borate buffer)) and incubated at 60 1C for 60 min. The reaction was performed without any reducing agent to detect free cysteine only. The reaction was stopped by incubation on ice for 5 min. The sample was deproteinized by adding 200 ml HClO 4 containing 0.5 M EDTA and centrifuged. A volume of 50 ml of the supernatant was injected in a HPLC column and analysed as described previously. Cysteine was used as a standard.
For the determination of intracellular cysteine levels, cell pellets were resuspended and sonified in 500 ml borate buffer (2 M, pH 9.5). After centrifugation, 200 ml of the supernatant was reduced by adding 20 ml of tri-n-butylphosphine for 30 min at 4 1C, deproteinized using HClO 4 , and centrifuged again. A volume of 100 ml of the supernatant was mixed with 250 ml of 2 M borate buffer and thiol groups were derivatized using SBDF. HPLC analysis was performed as described above.
Quantification of lipid peroxidation and intracellular reactive oxygen species (ROS) Lipid peroxidation was measured by FACS analysis using C11-BODIPY. ROS were detected by flow cytometry using DCF according to the manufacturer's instructions (Molecular Probes, Inc., OR, USA).
Determination of the mitochondrial membrane potential
In all, 2 Â 10 5 cells were collected and stained with 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethyl-benzimidazolycarbocyanin iodide (JC-1; Biotium, Inc., Hayward, CA, USA) at a final concentration of 2.5 mg ml À1 in 500 ml PBS as described by von Haefen et al. (2004) . After incubation for 30 min at 37 1C, cells were washed and resuspended in 200 ml PBS. The mitochondrial membrane potential was measured by flow cytometry using a FACScan (Becton Dickinson, Heidelberg, Germany) equipped with CellQuest software. Data are presented as percentage of cells with lowered membrane potential (DCm).
Measurement of DNA fragmentation
To measure genomic DNA fragmentation, the nuclear DNA content was determined by flow cytometry (Gillissen et al., 2003) . Overall, 2 Â 10 5 cells were pelleted in a 96-well Ubottom plate and fixed in 200 ml of 2% (v v À1 ) formaldehyde in PBS on ice for 30 min. After fixation, DNA was precipitated with 100% ethanol for 15 min, pelleted and resuspended in PBS containing RNaseA (40 mg ml
À1
). Following incubation at 37 1C for 30 min, the pellet was resuspended in 200 ml of propidium iodide (PI, 50 mg ml À1 ) and incubated overnight in the dark at 4 1C. Nuclear DNA fragmentation was quantified by flow cytometric determination of hypodiploid DNA. Data were collected and analysed using FACScan flow cytometer with CellQuest software.
Immunofluorescence Surface expression of death receptors was determined via direct immunofluorescence by the use of a FACScan flow cytometer (Becton-Dickinson, Heidelberg, Germany) on a single cell level. PE-labelled antibodies for CD95/Fas (clone DX2), TRAIL receptor 1/DR4 (clone DJR1), Trail R2/DR5 (clone DJR2-4) and a PE-labelled non-binding control antibody (clone P3, mouse IgG1 k) were from eBioscence (San Diego, CA, USA). Histograms are shown for 10 000 events acquired in a 256-channel resolution. Percentages of positive cells were determined by setting markers in relation to control stained cultures.
Protein extraction and immunoblotting
Cells were washed twice with PBS and lysed in buffer containing 10 mM Tris-HCl pH 7.5, 300 mM NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5mM EDTA, 1 mM pepstatin, 1 mM leupeptin and 0.1 mM phenylmethylsulfonyl fluoride. Protein concentration was determined using the bicinchoninic acid assay (Pierce, Rockford, IL, USA), and equal amounts of protein (usually 20 mg per lane) were separated by SDS-PAGE. Immunoblotting was performed as described (Wieder et al., 2001) . For protein visualization the following antibodies were used: the mouse monoclonal antibodies anti-Bax YTH-2D2 (1:10 000, Trevigen, Gaithersburg, MA, USA) and antiBcl-2 100/D5 (1:100) (Novocastra, Newcastle upon Tyne, UK), and the rat monoclonal antibody anti-Bcl-w (16H12, 1:1000) (Alexis). Anti-PUMA (N-19, 1:100), anti-Bid (C-20, 1:1000) and anti-Nbk/Bik (N-19, 1:1000) were polyclonal goat antibodies from Santa Cruz. All other reagents were polyclonal rabbit antibodies used in a dilution of 1:1000. Anti-Bak antibodies were purchased from Dako, anti-Bcl-x and antiBad antibodies from Transduction Laboratories, anti-Bim and anti-p53 from PharMingen, and anti-b-actin antibodies from Sigma. Protein bands were detected using the enhanced chemiluminescence system (Amersham Buchler, Braunschweig, Germany).
Detection of active caspases
Active caspases were determined by the FLICA apoptosis detection kit (Alexis GmbH, Gruenberg, Germany) according to the manufacturer's instructions. The methodology is based on the covalent binding of a fluorochrome-labelled inhibitor of caspases (FLICA) to the active site (Ekert et al., 1999) . These inhibitors (VDVAD-AFC for caspase 2; DEVD-AFC for caspase 3; IETD-AFC for caspase 8 and LEHD-AFC for caspase 9) are cell permeable and non-cytotoxic. The number of cells with active caspase was determined by FACScan flow cytometry using the CellQuest software. FITC-labelled FLICAs were used for staining and positive cells were measured in the FL-1 green channel.
Measurement of cell death by Annexin-V-FITC and propidium iodide staining Cell death was determined by staining cells with Annexin-V-FITC and counterstaining with PI. Cells were washed twice with cold PBS and resuspended in buffer containing 10 mM N-(2-hydroxyethyl)piperazin-N 0 -3(propansulfonic acid)/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 . Next, 5 ml of Annexin-V-FITC (BD PharMingen, Heidelberg, Germany) and 10 ml PI (20 mg ml À1 , Sigma-Aldrich) were added. Analyses were performed using FACScan and CellQuest analysis software (Becton Dickinson, Heidelberg, Germany).
Statistical analysis
Comparison between groups was made by the Student's t-test.
A difference between groups with Po0.05 was considered significant.
